We are live on
!
Find out more
Ensign Peak Advisors Portfolio holdings
AUM
$53.7B
1-Year Est. Return
29.47%
This Fund
S&P 500
This Quarter
Est. Return
-3.67%
1 Year Est. Return
+29.47%
3 Year Est. Return
+102.45%
5 Year Est. Return
+139.11%
10 Year Est. Return
–
AUM
$40.3B
AUM Growth
-$1.82B
(-4.3%)
Cap. Flow
+$332M
Cap. Flow
% of AUM
0.83%
Top 10 Holdings %
Top 10 Hldgs %
25.24%
Holding
2,393
New
237
Increased
785
Reduced
642
Closed
83
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Mastercard
MA
|
+$231M |
| 2 |
Gilead Sciences
GILD
|
+$113M |
| 3 |
PG&E
PCG
|
+$102M |
| 4 |
iShares 1-3 Year Treasury Bond ETF
SHY
|
+$80.2M |
| 5 |
Allstate
ALL
|
+$64.4M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Visa
V
|
+$472M |
| 2 |
AbbVie
ABBV
|
+$121M |
| 3 |
iShares MSCI USA Value Factor ETF
VLUE
|
+$69.5M |
| 4 |
Salesforce
CRM
|
+$64.3M |
| 5 |
Home Depot
HD
|
+$62.4M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 20.24% |
| 2 | Healthcare | 19.03% |
| 3 | Financials | 13.02% |
| 4 | Consumer Discretionary | 9.39% |
| 5 | Industrials | 7.38% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
IMA
1676
ImageneBio Inc
IMA
$65.5M
| $321K | ﹤0.01% |
7,526
| – | – |
|
|
GAP
1677
The Gap Inc
GAP
$7.28B
| $321K | ﹤0.01% |
39,090
| – | – |
|
1678
QuinStreet
QNST
$916M
| $320K | ﹤0.01% |
30,520
-5,670
| -16% | -$64.5K |
|
1679
AerCap
AER
$24.3B
| $317K | ﹤0.01% |
7,500
+4,050
| +117% | +$179K |
|
|
LYRA
1680
DELISTED
LYRA THERAPEUTICS INC
LYRA
| $317K | ﹤0.01% |
1,264
+139
| +12% | +$41.1K |
|
1681
Plains GP Holdings
PAGP
$5.2B
| $317K | ﹤0.01% |
29,070
+24,740
| +571% | +$284K |
|
1682
CVR Energy
CVI
$3.39B
| $316K | ﹤0.01% |
+10,910
| New | +$344K |
|
1683
G-III Apparel Group
GIII
$1.55B
| $315K | ﹤0.01% |
21,061
| – | – |
|
1684
Safety Insurance
SAFT
$1.51B
| $315K | ﹤0.01% |
3,860
+1,960
| +103% | +$177K |
|
1685
Shenandoah Telecom
SHEN
$655M
| $315K | ﹤0.01% |
18,530
-2,690
| -13% | -$57.4K |
|
1686
TFI International
TFII
$12.1B
| $315K | ﹤0.01% |
3,300
+1,600
| +94% | +$155K |
|
1687
AdaptHealth
AHCO
$1.53B
| $314K | ﹤0.01% |
16,710
+4,360
| +35% | +$89.6K |
|
1688
HNI Corp
HNI
$3.17B
| $313K | ﹤0.01% |
11,793
| – | – |
|
1689
Upbound Group
UPBD
$1.26B
| $313K | ﹤0.01% |
17,850
-4,050
| -18% | -$101K |
|
|
HIBB
1690
DELISTED
Hibbett, Inc. Common Stock
HIBB
| $313K | ﹤0.01% |
6,289
-1,120
| -15% | -$58.8K |
|
1691
NETGEAR
NTGR
$663M
| $312K | ﹤0.01% |
15,557
| – | – |
|
1692
Patrick Industries
PATK
$2.91B
| $312K | ﹤0.01% |
10,680
| – | – |
|
|
DVAX
1693
DELISTED
Dynavax Technologies
DVAX
| $311K | ﹤0.01% |
29,750
| – | – |
|
1694
Clearway Energy Class C
CWEN
$4.9B
| $310K | ﹤0.01% |
+9,720
| New | +$358K |
|
|
SHOE
1695
Shoe Station Group
SHOE
$431M
| $310K | ﹤0.01% |
14,470
| – | – |
|
1696
Sonos
SONO
$2B
| $310K | ﹤0.01% |
22,300
| – | – |
|
1697
Stanley Black & Decker
SWK
$14.6B
| $310K | ﹤0.01% |
4,110
-625
| -13% | -$60.1K |
|
|
GRTS
1698
DELISTED
Gritstone bio, Inc. Common Stock
GRTS
| $310K | ﹤0.01% |
120,527
| – | – |
|
1699
Blink Charging
BLNK
$74.1M
| $308K | ﹤0.01% |
17,390
+6,710
| +63% | +$138K |
|
1700
Amphastar Pharmaceuticals
AMPH
$888M
| $306K | ﹤0.01% |
10,900
| – | – |
|
Similar funds
SCP
Ensign Peak Advisors's Q3 2022 Portfolio in Review
As of Q3 2022, Ensign Peak Advisors held 2,393 positions worth $40.3B, down 4.3% from $42.1B the previous quarter. Its ten largest holdings account for 25% of the portfolio.
Ensign Peak Advisors's Q3 2022 filing shows 237 new, 785 increased, 642 reduced and 83 closed positions. Its largest new stake was iShares 1-3 Year Treasury Bond ETF: 975,000 shares worth $79.2M. The largest sale was Visa, an estimated $472M.
By sector, the portfolio is most concentrated in Technology at 20% of assets, down from 20% a quarter earlier, followed by Healthcare and Financials.
- Ensign Peak Advisors's largest Q3 2022 buy was iShares 1-3 Year Treasury Bond ETF: 975,000 shares worth $79.2M.
- Ensign Peak Advisors added most to Mastercard in Q3 2022, an estimated $231M increase.
- Ensign Peak Advisors's biggest Q3 2022 reduction was AbbVie, cutting an estimated $121M.
- Ensign Peak Advisors fully exited Visa in Q3 2022, selling an estimated $472M.
- Ensign Peak Advisors's ten largest holdings make up 25% of its $40.3B portfolio in Q3 2022.
- Ensign Peak Advisors opened 237 new positions and closed 83 in Q3 2022.
- Ensign Peak Advisors's portfolio value fell 4.3% quarter-over-quarter to $40.3B.
Based on Ensign Peak Advisors's 13F filing for Q3 2022, filed 14 Nov 2022.